General

The following discussion and analysis should be read in conjunction with the other sections of this report on Form 10-Q, including Part I, Item 1.

We are an integrated manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold primarily to and through domestic health and natural food stores. Internationally, we market and distribute branded nutritional supplements and other natural products to and through health and natural product distributors and retailers. Our core business strategy is to acquire, integrate and operate businesses in the natural products industry that manufacture, market and distribute branded nutritional supplements. We believe that the consolidation and integration of these acquired businesses provide ongoing financial synergies through increased scale and market penetration, as well as strengthened customer relationships.

We manufacture and sell nutritional supplements and other natural products under numerous brands including Solaray®, KAL®, Nature's Life®, LifeTime®, Natural Balance®, bioAllers®, Herbs for Kids™, NaturalCare®, Health from the Sun®, Life-flo®, Organix South®, Pioneer® and Monarch Nutraceuticals™.

We own neighborhood natural food markets, which operate under the trade names The Real Food Company™, Thom's Natural Foods™ and Cornucopia Community Market™. We also own health food stores, which operate under the trade names Fresh Vitamins™, Granola's™, Nature's Discount™ and Warehouse Vitamins™.

We were formed in 1993 to effect a consolidation strategy in the fragmented vitamin, mineral, herbal and other nutritional supplements industry (the "VMS Industry"). Since our formation, we have completed numerous acquisitions of assets or stock. As a result of acquisitions, internal growth and cost management, we believe that we are well positioned to continue to capitalize on acquisition opportunities that arise in the VMS Industry.

Critical Accounting Policies

The preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America required us to make estimates and assumptions that affected the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of net sales and expenses during the reported periods. Significant estimates included values and lives assigned to acquired intangible assets, reserves for customer returns and allowances, uncollectible accounts receivable, valuation adjustments for slow moving, obsolete and/or damaged inventory and valuation and recoverability of long-lived assets. Actual results may differ from these estimates. Our critical accounting policies include the following:

Accounts Receivable-Provision is made for estimated bad debts based on periodic analysis of individual customer balances, including an evaluation of days sales outstanding, payment history, recent payment trends and perceived credit worthiness. If general economic conditions and/or customer financial condition were to change, additional provisions for bad debts may be required, which could have a material impact on the consolidated financial statements.

Inventories-Valuation adjustments are made for slow moving, obsolete and/or damaged inventory based on periodic analysis of individual inventory items, including an evaluation of historical usage and/or movement, age, expiration date and general condition. If market demand and/or consumer preferences are less favorable than historical trends or future expectations, additional valuation

adjustments for slow moving, obsolete and/or damaged inventory may be required, which could have a material impact on the consolidated financial statements.

Property, Plant and Equipment-Depreciation and amortization expense is impacted by our judgments regarding the estimated useful lives of assets placed in service. If the actual lives of assets are significantly less than expected, depreciation and amortization expense would be accelerated, which could have a material impact on the consolidated financial statements.

We evaluate the recoverability of our property, plant and equipment which are reviewed for possible impairment whenever events or circumstances indicate that the carrying amount of an asset group may not be recoverable. We measure recoverability of the asset group by comparison of its carrying amount to the future undiscounted cash flows we expect the asset group to generate. If we consider the asset group to be impaired, we measure the amount of any impairment as the difference between the carrying amount and the fair value of the impaired asset group.

Goodwill and Intangible Assets-Goodwill and intangible assets require estimates and a high degree of judgment in determining the initial recognition and measurement of goodwill and intangible assets, including factors and assumptions used in determining fair values and useful lives. Intangible assets with finite useful lives are amortized, while intangible assets with indefinite useful lives are not amortized. Amortizable intangible assets are reviewed for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. Goodwill and indefinite-lived intangible assets are tested annually for impairment and are tested for impairment between annual tests if an event occurs that would cause us to believe that value is impaired. The appropriateness of the indefinite-life classification of non-amortizable intangible assets is also reviewed as part of the annual testing or when circumstances warrant a change to a finite life. We perform our annual impairment testing as of September 30 each year, which is the last day of our fiscal year.

A two step process is used to test for goodwill impairment. The first step is to determine if there is an indication of impairment by comparing the estimated fair value of each reporting unit to its carrying value, including existing goodwill. Reporting unit fair values are estimated using discounted cash flow models as well as considering market and other factors. Goodwill is considered impaired if the carrying value of a reporting unit exceeds the estimated fair value. Upon an indication of impairment, a second step is performed to measure the amount of the impairment by comparing the implied fair value of the reporting unit's goodwill with its carrying value.

Intangible assets with indefinite useful lives are tested for impairment at the individual tradename level by comparing the fair value of the indefinite-lived intangible asset to its carrying amount. If the carrying amount of an indefinite-lived intangible asset exceeds its fair value, an impairment charge is recognized. Fair values of indefinite-lived intangible assets are determined based on discounted cash flows.

Amortizable intangible assets are reviewed for recoverability by comparing an asset group's carrying amount to the future undiscounted cash flows the asset group is expected to generate. If the asset group is considered to be impaired, the difference between the carrying amount and the fair value of the impaired asset group is recorded.

The ongoing uncertainty in general and economic conditions may continue to impact retail and consumer demand, as well as the market price of our common stock, and could negatively impact our future operating performance, cash flow and/or stock price and could result in additional goodwill and/or intangible asset impairment charges being recorded in future periods. Also, we periodically review our brands to achieve marketing, sales and operational synergies. These reviews could result in additional brands being consolidated or discontinued and could result in additional intangible asset impairment charges being recorded in future periods. Additional goodwill and/or intangible asset impairment charges could materially impact our consolidated financial statements. The valuation of goodwill and intangible assets is subject to a high degree of judgment, uncertainty and complexity.

Revenue Recognition-Revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the product has been shipped and the customer takes ownership and assumes the risk of loss; (3) the selling price is fixed or determinable; and (4) collection of the resulting receivable is reasonably assured. We believe that these criteria are satisfied upon shipment from our facilities or, in the case of our neighborhood natural food markets and health food stores, at the point of sale within these stores. Revenue is reduced by provisions for estimated returns and allowances, which are based on historical averages that have not varied significantly for the periods presented, as well as specific known claims, if any. No other significant deductions from revenue must be estimated at the point in time that revenue is recognized.

Our estimates and judgments related to our critical accounting policies, including factors and assumptions considered in making these estimates and judgments, did not vary significantly for the periods presented and had no material impact on the consolidated financial statements as reported.

New Accounting Standards

See Note 1 to the Condensed Consolidated Financial Statements for information regarding new accounting standards.

Results of Operations

    The following table sets forth certain consolidated statements of operations
data as a percentage of net sales for the periods indicated:

                                                  Three Months         Nine Months
                                                 Ended June 30,       Ended June 30,
                                                 2012      2011       2012      2011
    Net sales                                     100.0 %   100.0 %    100.0 %   100.0 %
    Cost of sales                                  50.2 %    49.6 %     50.1 %    48.8 %

    Gross profit                                   49.8 %    50.4 %     49.9 %    51.2 %
    Selling, general and administrative            36.3 %    36.0 %     35.8 %    36.1 %
    Amortization of intangible assets               1.0 %     0.9 %      1.0 %     0.9 %
    Impairment of intangible asset                  1.7 %     0.0 %      0.6 %     0.0 %

    Income from operations                         10.8 %    13.5 %     12.5 %    14.2 %
    Interest and other expense, net                 0.7 %     0.6 %      0.7 %     0.6 %

    Income before provision for income taxes       10.1 %    12.9 %     11.8 %    13.6 %
    Provision for income taxes                      3.3 %     4.6 %      4.1 %     4.9 %

    Net income                                      6.8 %     8.3 %      7.7 %     8.7 %

    Adjusted EBITDA(1)                             17.0 %    17.8 %     17.4 %    18.5 %

Comparison of the Three Months Ended June 30, 2012 to the Three Months Ended June 30, 2011

Net Sales. Net sales increased by $2.1 million, or 4.5%, to $49.6 million for the three months ended June 30, 2012 ("third quarter of fiscal 2012") from $47.5 million for the three months ended June 30, 2011 ("third quarter of fiscal 2011"). Net sales of branded nutritional supplements and other natural products increased by $0.8 million, or 1.8%, to $44.7 million for the third quarter of fiscal 2012 compared to $43.9 million for the third quarter of fiscal 2011. The increase in net sales of branded nutritional supplements and other natural products was primarily related to the net sales contributions of the fiscal 2011 and fiscal 2012 acquisitions, partially offset by a decrease in sales volume of branded

products to certain customers. The impact on net sales of branded products attributable to price changes was not material. Other net sales increased $1.3 million, or 39.1%, to $4.9 million for the third quarter of fiscal 2012 from $3.6 million for the third quarter of fiscal 2011. The increase in other net sales was primarily related to the net sales contributions of the fiscal 2012 acquisitions, partially offset by the closure of three health food stores and one natural food market during fiscal 2011 and fiscal 2012.

Gross Profit. Gross profit was $24.7 million for the third quarter of fiscal 2012 and $23.9 million for the third quarter of fiscal 2011. As a percentage of net sales, gross profit was 49.8% for the third quarter of fiscal 2012 and 50.4% for the third quarter of fiscal 2011. This decrease in gross profit percentage was primarily attributable to increased material costs due to vendor price increases and, to a lesser extent, changes in sales mix.

Selling, General and Administrative. Selling, general and administrative expenses were $18.0 million for the third quarter of fiscal 2012 and $17.1 million for the third quarter of fiscal 2011. As a percentage of net sales, selling, general and administrative expenses were 36.3% for the third quarter of fiscal 2012 and 36.0% for the third quarter of fiscal 2011.

Amortization of Intangible Assets. Amortization of intangible assets was $0.5 million for the third quarter of fiscal 2012 and $0.4 million for the third quarter of fiscal 2011. For each period, amortization expense was primarily related to intangible assets recorded in connection with acquisitions.

Impairment of Intangible Asset. During the third quarter of fiscal 2012, we recorded a non-cash intangible asset impairment charge of $0.9 million ($0.6 million after tax, or $0.06 per diluted share) related to the consolidation of our food, drug and mass market ("FDM") brands. The charge represented the entire carrying amount of the Alan James Group™ ("AJG") brand. Existing products under the AJG brand were combined under our primary FDM Body Gold® brand. We believe this brand consolidation provides increased efficiencies and synergies for our FDM products and customers.

Interest and Other Expense, Net. Net interest and other expense was $0.4 million for the third quarter of fiscal 2012 and $0.3 million for the third quarter of fiscal 2011 and primarily consisted of interest expense on indebtedness under our revolving credit facility.

Provision for Income Taxes. Our effective tax rate was 33.1% for the third quarter of fiscal 2012 and 35.5% for the third quarter of fiscal 2011. The decrease in the effective tax rate for the third quarter of fiscal 2012 was primarily related to a discrete tax benefit of $0.1 million.

Comparison of the Nine Months Ended June 30, 2012 to the Nine Months Ended June 30, 2011

Net Sales. Net sales increased by $7.9 million, or 5.5%, to $150.1 million for the nine months ended June 30, 2012 from $142.2 million for the nine months ended June 30, 2011. Net sales of branded nutritional supplements and other natural products increased by $6.8 million, or 5.1%, to $137.8 million for the nine months ended June 30, 2012 compared to $131.0 million for the nine months ended June 30, 2011. The increase in net sales of branded nutritional supplements and other natural products was primarily related to the net sales contributions of the fiscal 2011 and fiscal 2012 acquisitions and, to a lesser extent, an increase in sales volume of branded products to certain customers. The impact on net sales of branded products attributable to price changes was not material. Other net sales increased $1.1 million, or 10.1% to $12.3 million for the nine months ended June 30, 2012 from $11.2 million for the nine months ended June 30, 2011. The increase in other net sales was primarily related to the net sales contributions of the fiscal 2012 acquisitions, partially offset by the closure of three health food stores and one natural food market during fiscal 2011 and fiscal 2012.

Gross Profit. Gross profit increased by $2.2 million, or 3.0%, to $75.0 million for the nine months ended June 30, 2012 from $72.8 million for the nine months ended June 30, 2011. This increase in

gross profit was primarily attributable to the increase in net sales. As a percentage of net sales, gross profit decreased to 49.9% for the nine months ended June 30, 2012 from 51.2% for the nine months ended June 30, 2011. This decrease in gross profit percentage was primarily attributable to increased material costs due to vendor price increases and, to a lesser extent, changes in sales mix and increased manufacturing overhead costs related to the expansion of our liquid manufacturing operations.

Selling, General and Administrative. Selling, general and administrative expenses increased by $2.5 million, or 4.8%, to $53.8 million for the nine months ended June 30, 2012 from $51.3 million for the nine months ended June 30, 2011. This increase in selling, general and administrative expenses was primarily attributable to operational and transition costs related to the fiscal 2011 and fiscal 2012 acquisitions. As a percentage of net sales, selling, general and administrative expenses were 35.8% for the nine months ended June 30, 2012 compared to 36.1% for the nine months ended June 30, 2011.

Amortization of Intangible Assets. Amortization of intangibles was $1.4 million for the nine months ended June 30, 2012 and $1.2 million for the nine months ended June 30, 2011. For each period, amortization expense was primarily related to intangible assets recorded in connection with acquisitions.

Impairment of Intangible Asset. During the nine months ended June 30, 2012, we recorded a non-cash intangible asset impairment charge of $0.9 million ($0.6 million after tax, or $0.06 per diluted share) related to the consolidation of our FDM brands. The charge represented the entire carrying amount of the AJG brand. Existing products under the AJG brand were combined under our primary FDM Body Gold® brand. We believe this brand consolidation provides increased efficiencies and synergies for our FDM products and customers.

Interest and Other Expense, Net. Net interest and other expense was $1.1 million for the nine months ended June 30, 2012 and $0.8 million for the nine months ended June 30, 2011 and primarily consisted of interest expense on indebtedness under our revolving credit facility.

Provision for Income Taxes. Our effective tax rate was 34.8% for the nine months ended June 30, 2012 and 36.0% for the nine months ended June 30, 2011.

Adjusted EBITDA

Adjusted EBITDA (a non-GAAP measure) is defined in our debt covenants and performance measures as earnings before net interest and other expense, taxes, depreciation, amortization and intangible asset impairment. Adjusted EBITDA has some inherent limitations in measuring operating performance due to the exclusion of certain financial elements such as depreciation and amortization and is not necessarily comparable to other similarly-titled captions of other companies due to potential inconsistencies in the method of calculation. Furthermore, Adjusted EBITDA is not intended to be a substitute for cash flows from operating activities, as a measure of liquidity, or an alternative to net income in determining our operating performance in accordance with generally accepted accounting principles. Our use of an EBITDA-based metric should be considered within the following context:

º •
º We acknowledge that plant and equipment (while less important in our line of business due to outsourcing alternatives) are necessary to earn revenue based on our current business model.

º •
º Our use of an EBITDA-based measure of operating performance is not based on any belief about the reasonableness of excluding depreciation and amortization when measuring financial performance.

º •
º Our use of an EBITDA-based measure is supported by its importance to the following key stakeholders:

º •
º Analysts-who estimate our projected Adjusted EBITDA and other EBITDA-based metrics in their independently-developed financial models for investors;

º •
º Creditors-who evaluate our operating performance based on compliance with certain EBITDA-based debt covenants;

º •
º Investment Bankers-who use EBITDA-based metrics in their written evaluations and comparisons of companies within our industry; and

º •
º Board of Directors and Executive Management-who use EBITDA-based metrics for evaluating management performance relative to our operating budget and bank covenant compliance, as well as our ability to service debt and raise capital for growth opportunities, including acquisitions, which are a critical component of our stated strategy. Historically, we have recorded a monthly accrual for incentive compensation as a percentage of Adjusted EBITDA, which has been paid out to executive management, as well as other employees, upon completion of our annual audit.

The following table sets forth a reconciliation of net income to Adjusted EBITDA for each period included herein:

                                               Three Months          Nine Months
                                              Ended June 30,       Ended June 30,
                                              2012      2011       2012       2011
                                                     (dollars in thousands)
       Net income                            $ 3,352   $ 3,945   $ 11,593   $ 12,444
       Provision for income taxes              1,659     2,174      6,187      7,001
       Interest and other expense, net(1)        388       293      1,124        802
       Depreciation and amortization           2,203     2,023      6,411      5,998
       Impairment of intangible asset(2)         850         -        850          -

       Adjusted EBITDA                       $ 8,452   $ 8,435   $ 26,165   $ 26,245

º (2)
º A non-cash intangible asset impairment charge of $850 related to the consolidation of our food, drug and mass market brands was recorded for the three months and nine months ended June 30, 2012.

Our Adjusted EBITDA was $8.5 million for the third quarter of fiscal 2012 and $8.4 million for the third quarter of fiscal 2011. Adjusted EBITDA as a percentage of net sales was 17.0% for the third quarter of fiscal 2012 and 17.8% for the third quarter of fiscal 2011.

Our Adjusted EBITDA was $26.2 million for both the nine months ended June 30, 2012 and 2011. Adjusted EBITDA as a percentage of net sales decreased to 17.4% for the nine months ended June 30, 2012 from 18.5% for the nine months ended June 30, 2011.

Seasonality

We believe that our business is characterized by minor seasonality. However, sales to any particular customer or sales of any particular product can vary substantially from one quarter to the next based on such factors as industry trends, timing of promotional discounts, domestic and international economic conditions and acquisition-related activities. Excluding the effect of acquisitions, we have historically recorded higher branded products sales volume during the second fiscal quarter (January through March) due to increased interest in health-related products among consumers following the holiday season.

Liquidity and Capital Resources

We had working capital of $45.8 million as of June 30, 2012 compared to $42.3 million as of September 30, 2011. The increase in working capital was primarily the result of increases in cash and inventories partially offset by decreases in accounts receivable and prepaid expenses and other current assets and an increase in accounts payable.

Net cash provided by operating activities for the nine months ended June 30, 2012 was $23.4 million compared to $21.3 million for the comparable period in fiscal 2011. This increase in net cash provided by operating activities for the nine months ended June 30, 2012 was primarily attributable to changes in operating assets and liabilities, net of effects of acquisitions.

Net cash used in investing activities was $19.4 million for the nine months ended June 30, 2012 compared to $18.5 million for the comparable period in fiscal 2011. Our investing activities during these periods consisted of acquisitions of businesses and capital expenditures. The capital expenditures primarily related to buildings, building improvements related to facility consolidation efforts, distribution and manufacturing equipment and information systems.

During the nine months ended June 30, 2012, we acquired six businesses for $12.2 million in cash. On October 27, 2011, we acquired certain operating assets of Mia Rose Products, Inc. On November 22, 2011, we acquired certain operating assets of Collective Wellbeing, LLC. On January 16, 2012, we acquired certain operating assets of Nature's Discount, Inc. and Top Health. On January 27, 2012, we acquired certain operating assets of Your Crown and Glory, LLC. On March 2, 2012, we acquired certain operating assets of Treehouse Vitamins, LLC. On June 7, 2012, we acquired certain operating assets of Direct Access Network, Inc. During the nine months ended June 30, 2011, we acquired four businesses for $9.3 million in cash. On October 7, 2010, we acquired certain operating assets of TRC Nutritional Labs, Inc. October 14, 2010, we acquired certain operating assets of The Heritage Store, Inc. On February 24, 2011, we acquired certain operating assets of SunFeather Natural Soap Company, Inc. On May 26, 2011 we acquired certain operating assets of Skin by Ann Webb, LLC.

Net cash used in financing activities was $0.2 million for the nine months ended June 30, 2012 compared to $2.9 million for the comparable period in fiscal 2011. During these periods, financing activities primarily related to borrowings and repayments under our revolving credit facility, payments of deferred financing fees, purchases of common stock for treasury and proceeds from the issuance of common stock related to stock option exercises and the direct stock purchase plan.

In October 2007, we registered a direct stock purchase plan with the Securities and Exchange Commission. The purpose of this direct stock purchase plan is to provide a convenient way for existing stockholders, as well as new investors, to purchase shares of our common stock. A total of 1,500,000 shares of our common stock were registered under the plan with 13,986 shares purchased during the nine months ended June 30, 2012. As of June 30, 2012, there were 1,398,338 shares of common stock available for purchase.

On December 17, 2010, we amended and restated our revolving credit facility (the "Restated Credit Agreement"). The Restated Credit Agreement extends the term of the credit facility to December 2015, resets the available credit borrowings to $90 million with no automatic reductions and provides an accordion feature which can increase the available credit borrowings to $120 million subject to approval by the lenders and compliance with certain covenants and conditions. The lenders under the Restated Credit Agreement are Rabobank International and Wells Fargo. To date, we have not experienced any difficulties in accessing the available funds under the Restated Credit Agreement. Deferred . . .